CONTACT
+91 80 2808 2808
info@biocon.com
About Us
Overview
Who we are
Our Key Priorities
Board of Directors
Key Management Team
Our Legacy
Fact Sheet
Our Stories
Awards & Recognition
Products
Overview
Key Therapeutic Areas
Generics
Biosimilars
Novel Biologics
Branded Formulations
Businesses
Overview
Generics
Executive Leadership Team
API
Generic Formulations
Quality & Compliance
Manufacturing Operations
Research & Development
Regulatory Affairs
Biosimilars
Executive Leadership Team
Biocon Biosimilars
Global Portfolio
Wide Global Footprint
Quality & Compliance
Partners
Global Scale Manufacturing
Research & Development
Branded Formulations
Novel Biologics
Biocon and Novels
Novels in Pipeline
Research Services
Investors
Overview
Financial Fact Sheet
Financial Information
Annual Reports
Quarterly Reports
Key Figures (Annual & Quarterly)
Earnings Call Transcripts
Subsidiary Financials
Investor Presentations
Corporate Governance
Overview
Board of Directors
Board Committees
Our Leadership
Corporate Structure
Company History & Milestones
Governance Documents & Policies
Share Information
Share Graph
Share Series
Share Price Look Up
Investment Calculator
Share Price Alerts
Fragulizer
Dividends
Unclaimed and Unpaid Dividend
IEPF
Shareholder Services
Annual General Meeting
Postal Ballot
Investor Feedback
Investor FAQ
Financial Calendar
Stock Exchange Disclosures
Notice of Board Meeting
Investors Meeting
Press Release
Shareholding Pattern
Corporate Governance Report
Newspaper Advertisement
RPT Disclosure
Other Announcements & Disclosures
Analyst Coverage
Code Of Conduct
Email Subscription Services
Investor Contact
Careers
Overview
Working With Us
Now Hiring
Functions
Our Culture
Diversity And Inclusion
Learning & Development
Awards & Recognition
Benefits
Meet Our Employees
Career FAQ’s
Responsibility
Overview
Biocon Foundation
Social Impact
Partners
Grant-in-Aid
Awards and Recognition
Sustainability
Safer Workplace
An Environment of Change
Environmental Clearance
EHS Certifications
Biocon Academy
News
Overview
Press Releases
Company Statements
Media Stories
Image Gallery
Video Gallery
Events & Calendar
Media Contacts
More+
Contact Us
Blog
For Patients
Biocon in Malaysia
Group Companies
Syngene
Biocon BIologics
Bicara
Biocon Academy
Biocon
/
Investor Relations
/
Stock Exchange Disclosures
/
Notice of Board Meeting
NOTICE OF BOARD MEETING
STOCK EXCHANGE DISCLOSURES
Notice of Board Meeting
Investor Meeting
Press Release
Shareholding Pattern
Corporate Governance Report
Newspaper Advertisement
RPT Disclosure
Other Announcements and Disclosures
FY 2021-22
Oct-2021
06-Oct
Intimation for the Board Meeting and Trading Window Closure
05-Oct
Intimation for the Board Meeting and Trading Window Closure
FY 2020-21
Apr-2021
12-Apr
Intimation for the Board Meeting and Trading Window Closure
Jan-2021
05-Jan
Intimation for the Board Meeting and Trading Window Closure
Oct-2020
06-Oct
Notice of Board Meeting to be held on October 22, 2020 and Trading Window Closure
Jul-2020
07-Jul
Intimation for the Board Meeting and Trading Window Closure
Apr-2020
22-Apr
Intimation for the Board Meeting and Trading Window Closure
ARCHIVES
FY: From April 1 – March 31
Know more
about us
>> Generics
>> Biocon Academy
>> Biocon Malaysia
NOVEL BIOLOGICS
BIOSIMILARS
RESEARCH SERVICES
OUR CULTURE
BIOCON FOUNDATION
Previous
Next
Close
Test Caption
Test Description goes like this
